Total Safety Solutions For Small And Emerging Biopharma

By Steven Beales, Angela Pitwood, and Mike Demo, WCG Clinical

Small and emerging biopharma companies are challenged to find flexible, scalable pharmacovigilance (PV) partner models that provide dedicated teams to look at each new drug safety signal, deliver high-quality case processing, and offer well-rounded expertise in all facets of PV and clinical operations.

To serve these organizations, WCG offers the industry’s only Total Safety Solution — a technology-enabled suite of services and solutions that cover not only serious adverse event (SAE) assessment, but global submissions to investigators, ethics committees, regulatory authorities, institutional review boards (IRBs), and data-and-safety monitoring boards (DSMBs).